Vince Siebert

Vince Siebert

Auto-generated profile, based on publicly available information

Vince Siebert

Division of Cardiology, Department of Cardiology Loyola University Medical Center Maywood Illinois USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
VSVincent R. Siebert
Vincent R. Siebert
SBSanket Borgaonkar
Sanket Borgaonkar
XJXiaoming Jia
Xiaoming Jia
HNHong Loan Nguyen
Hong Loan Nguyen
Yochai BirnbaumYochai Birnbaum
Yochai Birnbaum
MAMahboob Alam
Mahboob Alam

22 July 2019 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
VSVince Siebert
Vince Siebert
JAJoseph Allencherril
Joseph Allencherril
YYYumei Ye
Yumei Ye
Xander WehrensXander Wehrens
Xander Wehrens
Yochai BirnbaumYochai Birnbaum
Yochai Birnbaum

7 August 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
VSVince Siebert
Vince Siebert
JGJake Goldstein
Jake Goldstein
RKRizwan Khan
Rizwan Khan
JLJohn Lopez
John Lopez
ADAmir Darki
Amir Darki
DDDemetrios Doukas
Demetrios Doukas
Background: Acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is the most common cause of mortality following AMI, and treatment algorithms vary widely. We report the results of an analysis using time‐sensitive, hemodynamic goals in the treatment of AMI‐CS in a single center study.Methods: Consecutive patients with AMI‐CS from November 2016 through December 2021 were included in our retrospective analysis. Clinical characteristics and outcomes were analyzed using the electronic medical records. We identified 63 total patients who were admitted to our center with AMI‐CS, and we excluded patients who did not have clear timing of AMI onset or CS onset. We evaluated the rate of survival to hospital discharge based on the quantity of certain time‐sensitive hemodynamic goals were met.Results: We identified 63 patients who met criteria for AMI‐CS, 39 (62%) of whom survived to hospital discharge. Odds of survival were closely related to the achievement of four time‐dependent goals: cardiac power output (CPO) >0.6 Watts (W), pulmonary artery pulsatility index (PAPi) >1, lactate <4 mmol/L, and 0.6 W, PAPi >1, <2 vasopressors, and lactate <4 mmol/L) at 24 h after treatment for AMI‐CS with in‐hospital mortality. Our data show, in line with previous data, that the higher number of goals met at 24 h was associated with improved in‐hospital mortality regardless of treatment strategy.

29 May 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
VSVincent R Siebert
Vincent R Siebert
AJAlan John
Alan John
AMAhmad Manshad
Ahmad Manshad
ADAmir Darki
Amir Darki
Background: Endomyocardial biopsy (EMB) remains the gold standard for cellular rejection surveillance in heart transplant recipients. Coronary artery fistula formation is a rare late and potentially catastrophic complication of repeated endomyocardial biopsies, without contemporary evidence on incidence or management. Case summary: A 47-year-old male was found to have a fistula between his right ventricle and his left anterior descending artery on an angiogram that was performed as a part of regular screening of coronary allograft vasculopathy. Given the low shunt fraction, asymptomatic nature, and lack of guidelines on definitive management, the patient is undergoing conservative management with regular surveillance. Discussion: Coronary artery fistulas were once thought to be rare complications of repeated EMB, but the true prevalence is likely to be higher than previously believed. Ideal treatment and monitoring is unknown given the relative rarity of the condition.